8-K ·Filed Jun 12, 2026

ABEO

ABEONA THERAPEUTICS INC.
NEUTRAL
Impact 2/10
Horizonimmediate Processed3mo ago SEC0001493152-26-028369
8-K context-dependent: Items 5.02
Actionable Insight • Neutral

This is a routine board departure with no trading implications. Monitor for any future board composition changes or patterns, but no action is warranted based on this filing alone.

DirectionNeutral
Confidencehigh
Horizonimmediate
Latest settled — T+20d
ABEO ▲ +26.22% at T+20d
NEUTRAL call ✓ call won +26.22% · α vs SPY +24.44% · entry $5.53 → $6.98
Next anchor: T+60d due 23d ago
Latest observation: T+58 +11.04% FF3 residual α
Entry anchored
Jun 11, 03:59 PM ET
via exchange tick
T+1d
+2.53%
call +2.53% · α +0.77%
$5.67
settled 4mo ago
T+5d
+4.34%
call +4.34% · α +3.67%
$5.77
settled 3mo ago
T+20d
+26.22%
call +26.22% · α +24.44%
$6.98
settled 3mo ago
T+60d
—
call — · α —
—
due 23d ago

Price Chart

Loading chart...

Executive Summary

Board member Michael Amoroso resigned from Abeona Therapeutics' Board of Directors and its Nominating and Corporate Governance Committee effective June 11, 2026, citing personal reasons. The filing explicitly states the resignation was not due to any disagreement with the company. This is a routine director departure with no operational or financial impact.

Key Facts

  • Michael Amoroso resigned from the Board of Directors effective June 11, 2026
  • Resignation also covered his role on the Nominating and Corporate Governance Committee
  • Resignation was for personal reasons, not due to any disagreement with the company
  • No replacement was named in the filing
  • No other officers or directors were impacted

Financial Impact

No financial impact

Risk Factors

  • Potential governance concerns if multiple board departures occur in a short period, though none indicated here

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
92% bullish (12 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001493152-26-028369
Document: 0001493152-26-028369-index-headers.html0001493152-26-028369
Document: 0001493152-26-028369-index.html0001493152-26-028369
Document: 0001493152-26-028369.txt0001493152-26-028369
19 reports for ABEO
Performance horizon
33% Hit rate 1 of 3 directional calls best @ T+1▲ +3.70%Aug 14, 2026
Filters
Rows
Reports for ABEO — sortable, filterable
TypeNow
Sep 15, 2026
17d ago
8-K
NEUTRAL ★ 2/10
$5.47 $5.57▲ +1.83%▲ +1.01%$5.03 (−8.14%)
Aug 14, 2026
6w ago
Institutional Cluster
BULLISH ★ 5/10
$5.94 $6.06▲ +2.02%▲ +3.21%$5.03 (−15.40%)
Aug 13, 2026
7w ago
8-K
NEUTRAL ★ 5/10
$6.35 $5.96▼ −6.07%▼ −4.10%$5.03 (−20.80%)
Aug 13, 2026
7w ago
Press Release
MIXED ★ 6/10
$6.35 $5.96▼ −6.07%▼ −4.10%$5.03 (−20.80%)
Jul 9, 2026
12w ago
Insider Cluster
NEUTRAL ★ 2/10
$6.98 $7.02▲ +0.57%▲ +1.13%$5.03 (−28.01%)
Jun 15, 2026
15w ago
Insider Cluster
NEUTRAL ★ 4/10
$5.65 $5.72▲ +1.24%▲ +3.47%$5.03 (−11.06%)
Jun 15, 2026
15w ago
Insider Cluster
BEARISH ★ 5/10
$5.65 $5.72▼ −1.24%▼ −3.47%$5.03 (+11.06%)
Jun 12, 2026
16w ago
8-K
NEUTRAL ★ 2/10
$5.53 $5.77▲ +4.34%▲ +3.67%$5.03 (−9.13%)
Jun 10, 2026
16w ago
8-K
NEUTRAL ★ 2/10
$5.53 $5.65▲ +2.17%▲ +1.74%$5.03 (−9.13%)
Jun 10, 2026
16w ago
Insider Cluster
BEARISH ★ 5/10
$5.36 $5.65▼ −5.41%▼ −1.98%$5.03 (+6.25%)
Showing 10 of 19

US Market Status

Market Open — Closes in 2h 17m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access